Literature DB >> 10407492

Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice.

M P de Winther1, M J Gijbels, K W van Dijk, P J van Gorp, H suzuki, T Kodama, R R Frants, L M Havekes, M H Hofker.   

Abstract

Apolipoprotein (apo) E3Leiden is a dysfunctional apo E variant associated with familial dysbetalipoproteinemia in humans. Transgenic mice carrying the APOE3Leiden gene develop hyperlipidemia and are highly susceptible to diet-induced atherosclerosis. An early step in atherosclerosis is foam cell formation, which is thought to result from the unrestricted uptake of modified lipoproteins by macrophages. To investigate the role of the macrophage scavenger receptor type I and II (MSR-A) in this process, APOE3Leiden transgenic mice were crossed onto a MSR-A deficient background and the development of atherosclerosis was examined. In view of recent results with apo E deficient mice (Suzuki H et al., A role for the macrophage scavenger receptors in atherosclerosis. Nature 1997; 386(6622):292-296), absence of the MSR-A in APOE3Leiden mice was expected to lead to a reduction of atherosclerosis. In our study we compared APOE3Leiden/MSR-A deficient mice (E3L MSR-A -/-) to APOE3Leiden/MSR-A wild-type mice (E3L MSR-A +/+). These animals were fed an atherogenic diet for 10 weeks. Quantification of the lesion area showed no significant difference between E3L MSR-A -/- and E3L MSR-A +/+ mice although there was a trend towards the development of larger lesions in the E3L MSR-A -/- mice. All lesions were typed according to their cellular composition. In both male and female E3L MSR-A -/- mice, significantly more severe lesions developed as compared to E3L MSR-A +/+ mice. These results indicate that the effect of MSR-A deficiency on atherogenesis may depend on the presence or absence of apo E.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407492     DOI: 10.1016/s0021-9150(98)00332-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  22 in total

1.  Scavenging new insights into atherogenesis.

Authors:  M P de Winther; M H Hofker
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 2.  Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo.

Authors:  S D Yan; A Roher; A M Schmidt; D M Stern
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

3.  Targeting Innate Immunity for CV Benefit.

Authors:  Kathryn J Moore; Mason W Freeman
Journal:  Drug Discov Today Ther Strateg       Date:  2008

4.  Macrophages create an acidic extracellular hydrolytic compartment to digest aggregated lipoproteins.

Authors:  Abigail S Haka; Inna Grosheva; Ethan Chiang; Adina R Buxbaum; Barbara A Baird; Lynda M Pierini; Frederick R Maxfield
Journal:  Mol Biol Cell       Date:  2009-10-07       Impact factor: 4.138

Review 5.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Authors:  Irena Levitan; Suncica Volkov; Papasani V Subbaiah
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

Review 6.  Class A1 scavenger receptors in cardiovascular diseases.

Authors:  Jingjing Ben; Xudong Zhu; Hanwen Zhang; Qi Chen
Journal:  Br J Pharmacol       Date:  2015-03-27       Impact factor: 8.739

Review 7.  From proliferation to proliferation: monocyte lineage comes full circle.

Authors:  Filip K Swirski; Ingo Hilgendorf; Clinton S Robbins
Journal:  Semin Immunopathol       Date:  2014-01-17       Impact factor: 9.623

8.  Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.

Authors:  Kathryn J Moore; Vidya V Kunjathoor; Stephanie L Koehn; Jennifer J Manning; Anita A Tseng; Jessica M Silver; Mary McKee; Mason W Freeman
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

9.  Modified low density lipoproteins binding requires a lysine cluster region in the murine macrophage scavenger receptor class A type II.

Authors:  Francisco J Leyva; Mark A Pershouse; Andrij Holian
Journal:  Mol Biol Rep       Date:  2009-09-23       Impact factor: 2.316

10.  IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages.

Authors:  Khatuna Gabunia; Stephen Ellison; Sheri Kelemen; Farah Kako; William D Cornwell; Thomas J Rogers; Prasun K Datta; Mireille Ouimet; Kathryn J Moore; Michael V Autieri
Journal:  Am J Pathol       Date:  2016-03-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.